• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代表意大利放射治疗和临床肿瘤学协会(AIRO)对老年头颈部癌症患者进行的调查结果。

Results of a survey on elderly head and neck cancer patients on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

机构信息

Health Science Department (DISSAL), University of Genoa, Italy.

Radiation Oncology Department, Policlinico San Martino Hospital, Genoa, Italy.

出版信息

Acta Otorhinolaryngol Ital. 2020 Dec;40(6):405-409. doi: 10.14639/0392-100X-N0618.

DOI:10.14639/0392-100X-N0618
PMID:33558767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7889254/
Abstract

OBJECTIVE

Over the years, evidence-based data and technical improvements have consolidated the central role of radiation therapy (RT) in head and neck cancer (HNC) treatment, even in the elderly. This survey aimed to describe the management of the elderly HNC patients among Italian Radiation Oncology Departments (RODs) and provide possible suggestions for improvement.

METHODS

An online survey based on 43 questions was sent to RODs via email. For each RODs, a radiation oncologist with expertise in HNC was invited to answer questions addressing his/her demographic data, ROD multidisciplinary unit (MU) organisation and ROD management policy in elderly HNC patients.

RESULTS

In total, 68 RODs answered, representing centres located in 16 Italian regions. MU was considered the core of HNC patient management in almost all the entire country. However, in many RODs, there was minimal access to a routinely comprehensive geriatric assessment at diagnosis. Most treatments were reported by respondents as curative (89% on average) and the preferred treatment technique was intensity modulated radiation therapy (IMRT). A considerable variation between RODs was found for RT target volumes. There was a relation between the specialist's years of experience and type of concomitant systemic therapy prescribed.

CONCLUSIONS

Substantial differences in elderly HNC management have been found, especially concerning patient clinical evaluation and target volume delineation. This survey shows the necessity to design a prospective national trial to provide a uniform treatment strategy and define an effective patient-centred approach.

摘要

目的

多年来,循证数据和技术进步巩固了放射治疗(RT)在头颈部癌症(HNC)治疗中的核心作用,即使是在老年人中也是如此。本研究旨在描述意大利放射肿瘤学部门(ROD)对老年 HNC 患者的管理,并为改进提供可能的建议。

方法

通过电子邮件向 ROD 发送了一项基于 43 个问题的在线调查。为每个 ROD,邀请一位在 HNC 方面具有专业知识的放射肿瘤学家回答关于其人口统计学数据、ROD 多学科单位(MU)组织以及 ROD 对老年 HNC 患者管理政策的问题。

结果

共有 68 个 ROD 做出了回应,代表了分布在意大利 16 个地区的中心。MU 被认为是 HNC 患者管理的核心,几乎遍及全国。然而,在许多 ROD 中,在诊断时很少有机会进行常规的全面老年评估。大多数治疗方法被受访者认为是治愈性的(平均 89%),首选的治疗技术是调强放射治疗(IMRT)。ROD 之间在 RT 靶区方面存在相当大的差异。专家的经验年限与规定的同时系统治疗类型之间存在关联。

结论

在老年 HNC 管理方面存在很大差异,尤其是在患者的临床评估和靶区勾画方面。本研究表明有必要设计一项前瞻性的全国性试验,以提供统一的治疗策略并定义有效的以患者为中心的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d8f/7889254/691e9d441739/aoi-2020-06-405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d8f/7889254/691e9d441739/aoi-2020-06-405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d8f/7889254/691e9d441739/aoi-2020-06-405-g001.jpg

相似文献

1
Results of a survey on elderly head and neck cancer patients on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).代表意大利放射治疗和临床肿瘤学协会(AIRO)对老年头颈部癌症患者进行的调查结果。
Acta Otorhinolaryngol Ital. 2020 Dec;40(6):405-409. doi: 10.14639/0392-100X-N0618.
2
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO).头颈部鳞状细胞癌患者的根治性再照射:代表意大利放射肿瘤学会(AIRO)进行的全国常规实践调查。
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):561-567. doi: 10.1007/s00405-017-4853-8. Epub 2017 Dec 26.
3
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.COVID-19 大流行期间头颈部癌症患者放射治疗的现状:意大利放射治疗和临床肿瘤学协会(AIRO)头颈部工作组的调查。
Radiol Med. 2021 Feb;126(2):343-347. doi: 10.1007/s11547-020-01296-7. Epub 2020 Oct 6.
4
Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.代表意大利放射肿瘤学会头颈工作组发布的头颈癌调强放射治疗技术指南
Radiat Oncol. 2014 Dec 29;9:264. doi: 10.1186/s13014-014-0264-9.
5
Patterns of postoperative radiotherapy for head and neck cancer in Italy: a prospective, observational study by the head and neck group of the Italian Association for Radiation Oncology (AIRO).意大利头颈部癌术后放疗模式:意大利放射肿瘤学协会(AIRO)头颈部组的一项前瞻性观察研究
Tumori. 2011 Mar-Apr;97(2):170-6. doi: 10.1177/030089161109700207.
6
Radiotherapy resources for the care of head and neck patients in Italy. A survey by the head and neck group of the Italian Association for Radiation Oncology (AIRO).意大利用于头颈部患者护理的放疗资源。意大利放射肿瘤学协会(AIRO)头颈组的一项调查。
Tumori. 2008 Jan-Feb;94(1):59-64. doi: 10.1177/030089160809400111.
7
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).M. D. 安德森症状量表头颈部(MDASI-HN)问卷:接受放疗 ± 系统治疗的头颈部癌症患者的意大利语心理测量学验证-意大利放射肿瘤学和临床肿瘤学会(AIRO)的研究。
Oral Oncol. 2021 Apr;115:105189. doi: 10.1016/j.oraloncology.2021.105189. Epub 2021 Feb 4.
8
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).前列腺癌局部复发:外照射再放疗治疗的调查:意大利放射治疗和临床肿瘤学协会(AIRO)的结果。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2311-2317. doi: 10.1007/s00432-020-03297-5. Epub 2020 Jun 24.
9
Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).针对不明原发灶的头颈部癌症的治疗模式分析:德国放射肿瘤学会(DEGRO)内部调查。
Strahlenther Onkol. 2018 Aug;194(8):750-758. doi: 10.1007/s00066-018-1308-0. Epub 2018 May 14.
10
Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.颈部淋巴结转移原发灶不明的根治性放疗中临床靶区勾画的观察者间变异性。意大利放射肿瘤学和临床肿瘤学协会(AIRO)头颈部肿瘤协作组的一项合作研究。
Radiol Med. 2019 Jul;124(7):682-692. doi: 10.1007/s11547-019-01006-y. Epub 2019 Mar 9.

引用本文的文献

1
Curative treatment incorporating subjective decisions on age and frailty is not beneficial for older patients with oral cavity squamous cell carcinoma.包含基于年龄和虚弱程度的主观决策的根治性治疗对老年口腔鳞状细胞癌患者并无益处。
PLoS One. 2025 Aug 25;20(8):e0330376. doi: 10.1371/journal.pone.0330376. eCollection 2025.
2
Frailty and Overall Survival of Older Patients Undergoing Radiotherapy for Head and Neck Cancer: A Prospective Analysis.老年头颈癌患者放疗后的衰弱状况与总生存期:一项前瞻性分析
Cancers (Basel). 2024 Nov 25;16(23):3939. doi: 10.3390/cancers16233939.
3
Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer.

本文引用的文献

1
The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.年龄在头颈癌患者治疗相关不良事件中的作用:一项系统综述。
Head Neck. 2019 Jul;41(7):2410-2429. doi: 10.1002/hed.25696. Epub 2019 Feb 9.
2
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.NCCN 指南解读:头颈部肿瘤,第 1.2018 版。
J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.
3
The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.
老年头颈部癌症患者的临床和治疗注意事项。
Clin Interv Aging. 2023 Mar 17;18:409-422. doi: 10.2147/CIA.S366155. eCollection 2023.
4
Management of Older Adults with Locally Advanced Head and Neck Cancer.局部晚期头颈癌老年患者的管理
Cancers (Basel). 2022 Jun 5;14(11):2809. doi: 10.3390/cancers14112809.
5
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy.老年患者头颈部鳞状细胞癌:放疗与化疗的作用
Cancers (Basel). 2022 Jan 18;14(3):472. doi: 10.3390/cancers14030472.
局部区域晚期头颈部鳞状细胞癌的老年患者:评估与治疗中的知识空白及未来方向
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):868-883. doi: 10.1016/j.ijrobp.2017.02.022.
4
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer.多学科方法对头颈部癌(化疗)放疗患者的益处。
Curr Treat Options Oncol. 2016 Oct;17(10):53. doi: 10.1007/s11864-016-0431-3.
5
Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌根治性加速调强放射治疗后选择性照射淋巴结区域的复发模式
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):766-74. doi: 10.1016/j.ijrobp.2015.12.002. Epub 2015 Dec 13.
6
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.老年癌症患者脆弱性筛查:ONCODAGE前瞻性多中心队列研究
PLoS One. 2014 Dec 11;9(12):e115060. doi: 10.1371/journal.pone.0115060. eCollection 2014.
7
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†.筛查工具用于多维健康问题,这些问题需要对老年癌症患者进行老年评估:SIOG 建议的更新†。
Ann Oncol. 2015 Feb;26(2):288-300. doi: 10.1093/annonc/mdu210. Epub 2014 Jun 16.
8
Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR).综合老年评估对老年头颈癌患者生存、功能及营养状况的影响:一项多中心随机对照试验(EGeSOR)方案
BMC Cancer. 2014 Jun 13;14:427. doi: 10.1186/1471-2407-14-427.
9
Optimal treatment for recurrent/metastatic head and neck cancer.复发性/转移性头颈部癌的最佳治疗方法。
Ann Oncol. 2010 Oct;21 Suppl 7:vii252-61. doi: 10.1093/annonc/mdq453.
10
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.放疗联合西妥昔单抗治疗局部晚期头颈部癌:III 期随机试验的 5 年生存数据,以及西妥昔单抗诱导皮疹与生存的关系。
Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10.